CAS 62952-06-1

Aspisol

Descrição:

Aspisol, com o número CAS 62952-06-1, é um composto químico conhecido principalmente por sua aplicação na indústria farmacêutica, particularmente como um anti-inflamatório não esteroidal (AINE). Apresenta propriedades analgésicas, antipiréticas e anti-inflamatórias, tornando-o útil para tratar dor, febre e inflamação. Aspisol atua inibindo as enzimas ciclooxigenases (COX), que desempenham um papel crucial na síntese de prostaglandinas, compostos que mediam a inflamação e a dor. A substância é tipicamente administrada em várias formulações, incluindo comprimidos e aplicações tópicas, e é caracterizada por seu perfil de toxicidade relativamente baixo em comparação com outros AINEs. No entanto, como todos os medicamentos, pode ter efeitos colaterais, incluindo desconforto gastrointestinal e potenciais riscos cardiovasculares, particularmente com o uso a longo prazo. Sua farmacocinética envolve processos de absorção, distribuição, metabolismo e excreção que são essenciais para determinar sua eficácia e segurança no uso clínico. No geral, Aspisol é um composto significativo no campo do manejo da dor e controle da inflamação.

Fórmula: C₉H₈O₄·C₆H₁₄N₂O₂

InChI: InChI=1S/C9H8O4.C6H14N2O2/c1-6(10)13-8-5-3-2-4-7(8)9(11)12;7-4-2-1-3-5(8)6(9)10/h2-5H,1H3,(H,11,12);5H,1-4,7-8H2,(H,9,10)

Chave InChI: InChIKey=JJBCTCGUOQYZHK-UHFFFAOYSA-N

SMILES: C(CCCCN)(C(O)=O)N.C(O)(=O)C1=C(OC(C)=O)C=CC=C1

Sinónimos:

• 2,6-Diaminohexanoic Acid Compound With 2-Acetoxybenzoic Acid (1:1)
• 6-Ammonionorleucine 2-(Acetyloxy)Benzoate
• <span class="text-smallcaps">DL</span>-Lysine acetylsalicylate
• <span class="text-smallcaps">DL</span>-Lysine aspirin salt
• <span class="text-smallcaps">DL</span>-Lysine, mono[2-(acetyloxy)benzoate]
• Acelysin
• Acelysine
• Acetylsalicylic acid <span class="text-smallcaps">DL</span>-lysine salt
• Acetylsalicylic acid dl-lysine salt
• Acetylsalicylic acid lysine salt
• Asalis
• Aspegic
• Aspidol
• Aspirin <span class="text-smallcaps">D</smallcap><smallcap>L</span>-lysine
• Aspirin DL-lysine
• Aspirin Lysine
• Aspirin lysine salt
• Aspirisine
• Aspisol
• Atselizin
• Benzoic acid, 2-(acetyloxy)-, compd. with <span class="text-smallcaps">DL</span>-lysine (1:1)
• Benzoic acid, 2-(acetyloxy)-, compd. with lysine (1:1)
• Cogla
• DL-Lysine acetylsalicylate
• Delgesic
• Egicalm
• Laboprin
• Lysal
• Lysine acetylsalicylate
• Lysine monosalicylate acetate
• Lysine, 2-(acetyloxy)benzoate (1:1)
• Lysine, mono[2-(acetyloxy)benzoate]
• Lysini racemici acetylsalicylase
• Quinvet
• Solpirin
• Venopirin
• Vetalgina
• Vetalgine
• o-Acetylsalicylic acid <span class="text-smallcaps">D</smallcap>,<smallcap>L</span>-lysine salt
• DL-Lysine, mono[2-(acetyloxy)benzoate]

DL-LYSINE ACETYLSALICYLATE CRS

CAS: 62952-06-1

DL-LYSINE ACETYLSALICYLATE CRS

Ref: 41-Y0002211

DL-Lysine Acetylsalicylate

CAS: 62952-06-1

Fórmula: C₁₅H₂₂N₂O₆

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 326.3450

Ref: IN-DA01CC6I

DL-Lysine Acetylsalicylate

CAS: 62952-06-1

Fórmula: C₉H₈O₄·C₆H₁₄N₂O₂

Pureza: >98.0%(T)(HPLC)

Cor e Forma: White to Light yellow powder to crystal

Peso molecular: 326.35

Ref: 3B-A3744

DL-Lysine Acetylsalicylate

Produto Controlado

CAS: 62952-06-1

Applications Non-steroidal anti-inflammatory drugs (NSAIDs) may inhibit cancer growth. Water soluble, injectable aspirin derivative.Analgesic; antipyretic; anti-inflammatory.
References Korttila, K., et al.: Br. J. Anaesth, 52, 613 (1980), Diaz, C., et al.: Clin. Ther., 4, 121 (1981), Wolff, F., et al.: Arch. Gynecol., 233, 15 (1982), Bretagne, J.-F., et al.: Gastroenterol. Clin. Biol., 8, 28 (1984),

Fórmula: C₉H₈O₄·C₆H₁₄N₂O₂

Cor e Forma: Neat

Peso molecular: 326.34

Ref: TR-L488500

Aspirin DL-lysine

CAS: 62952-06-1

Aspirin DL-lysine: a water-soluble, injectable NSAID that may also hinder cancer growth.

Fórmula: C₁₅H₂₂N₂O₆

Cor e Forma: Crystalline Solid

Peso molecular: 326.35

Ref: TM-T20458

DL-Lysine acetylsalicylate

CAS: 62952-06-1

L-Lysine acetylsalicylate is a nonsteroidal anti-inflammatory drug that has been shown to have analgesic and anti-inflammatory properties. L-Lysine acetylsalicylate has been shown to inhibit the activity of the enzyme cyclooxygenase, which is responsible for the production of prostaglandins from arachidonic acid. This inhibition leads to decreased levels of prostaglandins and a decrease in inflammation. L-Lysine acetylsalicylate also inhibits the activity of platelets, which are necessary for blood clotting. It does not affect the brain infarction process, but does increase cerebral blood flow in glioma patients. L-Lysine acetylsalicylate has been shown to be an effective treatment against cervical cancer cells in cell culture experiments. The molecular weight of this compound is 584 Da and it contains 8 atoms of oxygen that can be replaced with chloride ions or acet

Fórmula: C₉H₈O₄•C₆H₁₄N₂O₂

Pureza: Min. 95%

Cor e Forma: Powder

Peso molecular: 326.35 g/mol

Ref: 3D-FL24964